Nexium and Timentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nexium (esomeprazole magnesium) and Timentin (clavulanate potassium; ticarcillin disodium). Common drug interactions include alanine aminotransferase increased among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Nexium and Timentin. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Nexium?

Nexium has active ingredients of esomeprazole magnesium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 245,678 Nexium users. Check the latest studies of Nexium.

What is Timentin?

Timentin has active ingredients of clavulanate potassium; ticarcillin disodium. eHealthMe is studying from 624 Timentin users. Check the latest studies of Timentin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

30 people who take Nexium and Timentin together, and have interactions are studied.

Nexium and Timentin drug interactions.

What are the common drug interactions of Nexium and Timentin, by gender? *:

female:

  1. Alanine aminotransferase increased
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Breast cancer metastatic
  4. Decreased interest
  5. Deformity (disfigurement)
  6. Discomfort
  7. Dizziness
  8. Dysgeusia (disorder of the sense of taste)
  9. Dyspepsia (indigestion)
  10. Emotional distress

male:

  1. Alanine aminotransferase increased
  2. Fall
  3. Chills (felling of cold)
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Confusional state
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Device related infection
  8. Diastolic dysfunction
  9. Fatigue (feeling of tiredness)
  10. Hypertension (high blood pressure)

What are the common drug interactions of Nexium and Timentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Infusion site erythema (reddening of the skin at infusion site)
  2. Infusion site necrosis (death of body tissue at infusion site)
  3. Infusion site reaction
  4. Infusion site ulcer

30-39:

  1. Angioedema (rapid swelling of the dermis)
  2. Dyspnoea (difficult or laboured respiration)

40-49:

  1. Pleural effusion (water on the lungs)
  2. Pneumonitis (inflammation of the walls of the alveoli in the lungs)

50-59:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Cold sweat
  4. Confusional state
  5. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  6. Diabetes mellitus inadequate control
  7. Diabetic nephropathy (diabetic kidney disease)
  8. Diarrhoea
  9. Diastolic dysfunction
  10. Dilatation ventricular

60+:

  1. Anxiety
  2. Bone disorder
  3. Pyrexia (fever)
  4. Dizziness
  5. Ascites (accumulation of fluid in the abdominal cavity)
  6. Breast cancer metastatic
  7. Decreased interest
  8. Deformity (disfigurement)
  9. Discomfort
  10. Dysgeusia (disorder of the sense of taste)

What are the existing conditions these people have? *

  1. Pain: 10 people, 33.33%
  2. Stress And Anxiety: 9 people, 30.00%
  3. Reflux Gastritis (a condition in which the lining of a person's stomach becomes inflamed as a result of exposure to bile): 9 people, 30.00%
  4. Breast Cancer: 9 people, 30.00%
  5. High Blood Pressure: 6 people, 20.00%
  6. Constipation: 5 people, 16.67%
  7. Multiple Myeloma (cancer of the plasma cells): 5 people, 16.67%
  8. High Blood Cholesterol: 5 people, 16.67%
  9. Fever: 4 people, 13.33%
  10. Hyperglycemia (high blood sugar): 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nexium and Timentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nexium and Timentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nexium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Timentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nexium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Timentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on esomeprazole magnesium and clavulanate potassium; ticarcillin disodium (the active ingredients of Nexium and Timentin, respectively), and Nexium and Timentin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: